HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Milena Sant Selected Research
Milena Sant Research Topics
Disease
26
Neoplasms (Cancer)
11/2023 - 07/2002
20
Breast Neoplasms (Breast Cancer)
08/2021 - 06/2010
3
Colonic Neoplasms (Colon Cancer)
01/2020 - 12/2012
3
Disease Progression
01/2020 - 11/2017
2
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2022 - 01/2020
2
Inflammation (Inflammations)
06/2019 - 01/2016
2
Obesity
01/2016 - 12/2013
2
Lung Neoplasms (Lung Cancer)
10/2015 - 12/2012
1
Pain (Aches)
11/2023
1
Multiple Sclerosis
12/2021
1
Noninfiltrating Intraductal Carcinoma (DCIS)
02/2020
1
Philadelphia Chromosome
01/2020
1
Hypertension (High Blood Pressure)
01/2020
1
Cardiotoxicity
01/2018
1
Overweight
01/2016
1
Hyperplasia
01/2016
1
Insulin Resistance
01/2016
1
Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2016
1
Non-Hodgkin Lymphoma (Lymphosarcoma)
12/2014
1
Hematologic Neoplasms (Hematological Malignancy)
12/2014
1
Leukemia
12/2014
1
Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
08/2014
1
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
08/2014
1
Colorectal Neoplasms (Colorectal Cancer)
10/2013
1
Melanoma (Melanoma, Malignant)
12/2012
1
Rectal Neoplasms (Rectal Cancer)
11/2012
1
Ovarian Neoplasms (Ovarian Cancer)
04/2012
1
Meningioma (Meningiomas)
08/2008
Drug/Important Bio-Agent (IBA)
6
Phenobarbital (Luminal)
FDA Link
09/2020 - 09/2013
6
Hormones (Hormone)
IBA
02/2020 - 03/2011
4
Estrogen Receptors
IBA
02/2020 - 03/2012
3
ORALIT (ORS)
IBA
01/2023 - 12/2014
3
Estrogens (Estrogen)
FDA Link
11/2017 - 09/2013
3
Indicators and Reagents (Reagents)
IBA
10/2015 - 07/2002
2
Tyrosine Kinase Inhibitors
IBA
01/2022 - 01/2020
2
Androgens
IBA
11/2017 - 01/2016
2
Testosterone (Sustanon)
FDA Link
11/2017 - 01/2016
2
Progesterone
FDA Link
Generic
12/2013 - 09/2013
2
Glucose (Dextrose)
FDA Link
Generic
12/2013 - 08/2013
1
Azathioprine (Imuran)
FDA Link
Generic
12/2021
1
Imatinib Mesylate (Gleevec)
FDA Link
01/2020
1
Biomarkers (Surrogate Marker)
IBA
06/2019
1
human ERBB2 protein
IBA
10/2018
1
Trastuzumab (Herceptin)
FDA Link
01/2018
1
Selective Estrogen Receptor Modulators (SERM)
IBA
01/2016
1
Gonadotropin-Releasing Hormone (GnRH)
FDA Link
01/2016
1
Aromatase Inhibitors
IBA
01/2016
1
C-Reactive Protein
IBA
01/2016
1
Asbestos
IBA
10/2015
1
Concise-Cap-C-Rynge
IBA
07/2015
1
Benzene (Benzole)
IBA
12/2014
1
Carcinogens
IBA
12/2014
1
antineoplaston A10 (A 10)
IBA
08/2014
1
Blood Glucose (Blood Sugar)
IBA
12/2013
1
Epidermal Growth Factor (EGF)
IBA
09/2013
Therapy/Procedure
13
Radiotherapy
01/2023 - 08/2008
10
Therapeutics
11/2023 - 03/2012
10
Drug Therapy (Chemotherapy)
01/2020 - 03/2012
3
Neoadjuvant Therapy
12/2019 - 06/2016
2
Segmental Mastectomy (Lumpectomy)
09/2017 - 03/2012
1
Ovariectomy (Oophorectomy)
11/2017
1
Lymph Node Excision (Lymph Node Dissection)
06/2016
1
Palliative Care (Palliative Therapy)
02/2014
1
Adjuvant Chemotherapy
08/2013
1
Terminal Care (Care, Terminal)
09/2009